Shukra Dushti and Semen Abnormalities: Notes for Third Prof BAMS

1. Shukra Dhatu basics

• Shukra is the 7th dhatu and the Sara of all dhatus. It is the basis of Vajikarana and Santana (progeny).
• Normal Shukra (Su.Sh.2/11): Sphatika-abha (crystal clear), Drava, Snigdha, Madhura, Madhu-gandhi, and like Taila or Madhu in appearance.
• Shukravaha srotas: root is Vrishana (testes) and Shepha (penis). Dushti of this srotas gives Klaibya, Shukra kshaya, and Shukra dosha.
• Nidana of Shukra dushti:
  • Ativyavaya (excessive coitus), Ayoni and Amaithuna (unnatural or untimely sex), and suppression of the urge to ejaculate.
  • Atiruksha, Atiushna, Katu, Amla and Lavana ahara, and Viruddha ahara.
  • Shoka, Bhaya, Chinta, and Krodha.
  • Vega-dharana, Ativyayama, Ratri jagarana, and Anashana.
  • Abhighata or injury to the Shepha or Vrishana, Prameha, and Jwara.
  • Vata and Pitta prakopa leading to Shukravaha srotodushti.

2. Ashta Shukra Dushti (8 types)

1. Vataja
2. Pittaja
3. Kaphaja
4. Kunapa gandhi
5. Granthi
6. Puti-puya
7. Kshina
8. Mutra-purisha gandhi (in some listings)

Features of each type (exam table)

Other related terms

• Shukra kshaya: Daurbalya, Mukha shosha, Pandutva, Sada, Shrama, Klaibya, and Shukra avisarga or Rakta-mishrita shukra.
• Shukra vriddhi: Ati-streekamata (excessive libido) and Shukrashmari.
• Klaibya (Charaka lists 4 types, Sushruta 6 types): Manasika, Dhwajabhanga, Jaraja, Shukra kshayaja and others. Revise these separately.

3. Chikitsa (general principles)

• Shukra-shodhana mahakashaya (Charaka): Kushta, Elavaluka, Katphala, Samudraphena, Kadamba and others.
• Shukrajanana (Charaka): Jivaka and Rishabhaka groups. Revise the full list from your text.
• Vrishya dravyas: Ashwagandha, Shatavari, Kapikachchu (Atmagupta), Gokshura, Musali, Vidari, Bala, Shilajatu, Masha.
• Yogas: Ashwagandha ghrita, Chyavanprasha, Vajikarana rasayana, Makaradhwaja, Kapikachchu pak, Shatavari ghrita.
• Pathya: Ksheera, Ghrita, Masha, Mamsa rasa, Shali rice, adequate sleep, and a stress-free life.
• Apathya: Ruksha-Katu ahara, Ativyavaya, and Vega-dharana.

4. Modern semen analysis (the correlation part)

Terminology

• Table 36-3 of Berek & Novak lists these terms (Berek & Novak's Gynecology, p. 2027-2028):
  • Normozoospermia: all parameters normal.
  • Oligozoospermia: reduced sperm numbers (mild to moderate 5-20 million/mL, severe <5 million/mL).
  • Asthenozoospermia: reduced motility.
  • Teratozoospermia: increased abnormal forms.
  • OAT: all three subnormal.
  • Azoospermia: no sperm in the semen.
  • Aspermia: no ejaculate.
  • Leucocytospermia: raised white cells.
  • Necrozoospermia: dead sperm.
• Other terms: Hypospermia (low volume), Polyzoospermia (excess count), and Haemospermia (blood in semen).

Normal reference values (WHO lower 5th centile)

Collection and handling points (Campbell-Walsh Urology)

• Use a nontoxic wide-mouthed container.
• Abstinence of 2 to 7 days was traditional, and abstinence should be as constant as possible between tests. Recent data favour shorter abstinence.
• The sample is allowed to liquefy for 30 minutes before evaluation. Viscosity should be a thread no longer than 2 cm.
• Normal colour is white to light grey. Yellow or green suggests infection or jaundice, and red suggests blood.
• At least two analyses 2 to 3 weeks apart are recommended, because results vary.
• A normal result does not guarantee fertility, and a low result does not prove infertility.

Causes of low volume (hypospermia)

• Ejaculatory duct obstruction.
• Hypoplasia of the prostate and seminal vesicles (severe androgen deficiency or CBAVD).
• Retrograde ejaculation.
• Neurological causes such as spinal cord injury, diabetes mellitus and multiple sclerosis.
• Drugs such as tamsulosin (alpha-blockers).

Azoospermia classification (Berek & Novak)

1. Pretesticular: hypothalamic-pituitary failure, such as Kallmann syndrome or hypogonadotropic hypogonadism.
2. Testicular: primary testicular failure, such as Klinefelter syndrome, Y chromosome microdeletions (AZFa, b, c), cryptorchidism, orchitis, and chemotherapy or radiation.
3. Posttesticular: obstruction, such as CBAVD, vasectomy, epididymal obstruction and infection.

Other causes of poor semen quality

• Varicocele (the most common correctable cause), infections (epididymo-orchitis, mumps orchitis), and heat exposure.
• Smoking, alcohol, obesity, drugs (anabolic steroids, sulfasalazine), and toxins.
• Endocrine disorders and genetic causes.

5. Quick Shukra dushti vs modern correlation

6. Likely viva and exam questions

1. Enumerate Ashta Shukra Dushti with lakshanas.
2. Write the Chikitsa of Shukra dosha.
3. List the Shukra-shodhana and Shukrajanana dravyas.
4. List the WHO normal semen parameters.
5. Classify azoospermia.
6. Name the Nidana of Shukra kshaya and its Chikitsa.

Recent Research on Ayurvedic Management of Oligozoospermia (Kshina Shukra)

1. Reviews and meta-analyses

• It included 14 studies with 248 patients (84 male, 164 female). Six were original studies and eight were case reports.
• The authors found limited sample sizes and no standardized protocols. They call for rigorous experimental research before efficacy and safety can be established.

• It included 4 clinical trials (5 publications). Only one was an RCT, so no RCT meta-analysis was possible.
• Against baseline in oligospermic men after 90 days, the review reported increases of 167% in sperm concentration, 59% in semen volume and 57% in motility. Testosterone rose 17% and LH rose 34%.
• The pooled observational data showed these gains:
  • Sperm concentration rose by 13.57 million/mL.
  • Motility rose by 8.5%.
  • Semen volume rose by 0.28 mL.
• No adverse effects were reported.
• The authors say the data are promising but too limited to be robust.

2. Clinical trials

• Thirty-five oligospermic men (total count below 20 million/mL) were enrolled, and 28 completed treatment. They received 100 mg of processed Shilajit twice daily for 90 days.
• Total sperm count rose 61.4% and motility improved. Semen malondialdehyde (an oxidative stress marker) fell 18.7%. Testosterone rose 23.5% and FSH rose 9.4%.
• Liver and kidney profiles were unchanged, so the dose looked safe.
• It was a single-arm study with no control group.

• This was a triple-blind trial of 100 men. They received 5 g/day of Ashwagandha root or 800 mg/day of pentoxifylline for 90 days.
• Ashwagandha raised sperm count by 12.5%, progressive motility by 21.4% and morphology by 25.6% from baseline.
• The two groups did not differ significantly, so Ashwagandha performed comparably to pentoxifylline. There were no major complications.

• Ashwagandha improved semen quality through effects on reproductive hormones and seminal oxidative stress (PMID 19501822).
• Mucuna pruriens improved male fertility through its action on the hypothalamic-pituitary-gonadal axis (PMID 18973898). I did not read these two abstracts in full.

3. Recent Ayurvedic case reports (2021-2025)

4. Preclinical and mechanistic work

• A 2024 mouse study of a herbomineral formulation, SP-Max, found it protected against busulfan-induced oligospermia by preventing loss of reproductive hormones (PMID 38123000).
• A 2023 in-silico, in-vitro and in-vivo study of Ashwagandha ghrita examined it as a "Vajikarana Rasayana" (PMID 36549367).
• Mucuna pruriens and its constituent L-DOPA reversed spermatogenic loss in animals by reducing ROS and apoptosis (PMID 23349947).

5. How to read this evidence

• Strongest evidence: Ashwagandha and Shilajit, each tested in small studies with 3-month follow-up. The only RCT I found for Ashwagandha enrolled infertile men generally, not oligozoospermia specifically, and compared it with pentoxifylline rather than placebo.
• Weakest evidence: the classical protocol of Shodhana, Vajikarana and counseling. It rests on single-patient case reports.
• Common gaps: small samples, no control group, short follow-up and non-standard formulations. Few studies report live birth.
• Practical point: modern guidelines still treat ICSI and treating the underlying cause (varicocele, infection, endocrine disorder) as standard care. These Ayurvedic studies are best described as supportive or adjunct evidence.

Possible dissertation or exam use

• Gap: well-designed RCTs of Shodhana plus Vajikarana in WHO-defined oligozoospermia, with sperm DNA fragmentation and pregnancy outcomes.
• Typical outcomes: sperm concentration, total motile count, FSH, LH, testosterone and seminal MDA.